Zydus Lifesciences wins US approval for prescription skin treatment cream
Zydus Lifesciences wins US approval for prescription skin treatment cream
Zydus Lifesciences wins US approval for prescription skin treatment cream
Zydus Lifesciences has received approval to manufacture Ammonium Lactate Cream, 12%, a prescription treatment for dry, scaly skin conditions. The product will be produced at the company's topical facility in Changodar, Ahmedabad. Viona Pharmaceuticals Inc. will handle its distribution in the USA market.
Ammonium Lactate Cream, 12% is designed to treat xerosis and ichthyosis vulgaris. It works by boosting skin hydration, easing itching, softening rough patches, and reducing scaling. As of December 2025, the cream generated annual USA sales of around $15 million, according to IQVIA MAT data.
This approval marks another milestone for Zydus Lifesciences. The company now holds 430 regulatory approvals and has submitted 505 Abbreviated New Drug Applications (ANDAs) since the 2003-04 financial year.
The cream will enter a market where detailed share metrics remain undisclosed, as such data is typically held privately by manufacturers. Zydus Lifesciences continues to expand its portfolio with this latest addition, reinforcing its presence in the US prescription dermatology sector.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.